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University of Pittsburgh, 2008
 
Low ankle-arm index (AAI), a marker of peripheral arterial disease, predicts incident disability 
in older adults.  Elevated pulse wave velocity (PWV), a measure of arterial stiffness, increases 
risk of cardiovascular events and mortality.  However, the relationship between PWV and 
mobility has not been well characterized in older adults.  To evaluate the potential local and 
systemic influences of vascular disease on physical function, we compared the associations of 
AAI and PWV with usual gait speed over eight years in the Health, Aging and Body 
Composition (Health ABC) Study.  The study population consisted of 2,066 participants (mean 
age ± SD 73.6 ± 2.8 years, 48.1% men, 37.8% black) with valid PWV, AAI and gait speed data 
at baseline after exclusion of those with either revascularization or angioplasty of the leg arteries.  
Random coefficient models were used to evaluate the relationships of both subclinical vascular 
disease measures with gait speed decline over time.  After adjustment for risk factors and 
comorbidities, each SD higher PWV was associated with a 0.008 m/s slower gait speed over the 
study period (SE 0.004, p = 0.03).  Compared to high-normal AAI (>1.3-1.4), low AAI and 
noncompressible arteries were each associated with slower gait speed over the study period: Beta 
(SE) = -0.10 (0.03), p < 0.001 for AAI <0.7, and Beta (SE) = -0.16 (0.04), p < 0.001 for 
noncompressible arteries.  The public health relevance of these findings is the potential 
contribution of subclinical vascular disease, particularly low AAI and noncompressible arteries, 
to poor physical function in aging. 
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1.0  INTRODUCTION 
Beginning in 1997, the Health, Aging and Body Composition (Health ABC) Study enrolled 
3,075 Medicare-eligible nondisabled men and women aged 70-79 years living in Pittsburgh, PA 
and Memphis, TN.  The study was designed to prospectively evaluate factors that may be 
associated with loss of strength and muscle mass and incident functional limitation in a large, 
biracial population of well-functioning older adults.  Currently in its 12th year of funding, Health 
ABC provides a unique opportunity to characterize the relationship between two measures of 
subclinical vascular disease and mobility decline in older adults.   
Recent research has identified significant associations of both overt and subclinical 
cardiovascular disease with frailty in older adults [1].  While contributions of clinical 
cardiovascular disease to frail health are expected, the functional consequences of subclinical 
disease are under recognized.   Often asymptomatic and undiagnosed, peripheral arterial disease 
(PAD) may lead to physical impairment via local disabling effects, including muscle weakness, 
impaired nerve function and leg pain [2].  Low values of AAI (<0.9) reflect obstructive 
atherosclerosis in the leg arteries [2] and predict functional decline and mortality in older adults.  
However, it is unclear whether high AAI (>1.3) or noncompressible arteries, which may reflect 
arterial calcification, are also associated with greater risk of mobility decline. 
A second measure of subclinical vascular disease available in Health ABC, aortic pulse 
wave velocity (PWV) has not been characterized in relation to functional decline.   Higher values 
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of PWV represent systemic vascular stiffness, which may cause injury to the fragile small 
vessels of target organs.  Recently, elevated PWV was identified as an important risk factor for 
cerebral small-vessel disease identified on brain MRI.  This cerebrovascular pathology may 
preferentially disrupt frontal-subcortical tracts involved in the execution of motor tasks such as 
walking [3].  However, it is not known whether arterial stiffness may influence physical 
function, and whether this relationship may be explained by reduced cognitive function. 
1.1 STATEMENT OF THE PROBLEM 
The purpose of this study is to evaluate the associations of two measures of subclinical 
cardiovascular disease, AAI and PWV, with physical function in older adults.  The primary 
outcome is decline in usual gait speed, a reliable and valid measure of physical function that 
predicts incident disability in older adults [4].  The study population consists of 2,066 Health 
ABC participants (mean age ± SD 73.6 ± 2.8 years, 48.1% men, 37.8% black).  Random 
coefficient models are used to evaluate the relationships of both subclinical vascular disease 
measures with gait speed decline over eight years.  Results may clarify the local and systemic 
influences of subclinical vascular disease on physical function in advancing age.  
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2.0  REVIEW OF THE LITERATURE 
Recent research has identified associations of both clinical and subclinical PAD with functional 
decline in older adults.  Among individuals with clinically diagnosed PAD, AAI and leg 
symptoms predicted 2-year decline in physical function [5].  For these analyses, generalized 
estimating equations (GEE) were used to perform repeated-measures analysis of covariance 
(ANCOVA).  The models compared annual changes in physical performance, including walking 
distance, across patient groups defined by three AAI categories or severity of leg symptoms. 
Results indicated that lower baseline AAI and leg symptoms each predicted greater decline 
physical function over two years.  These findings demonstrate the clinical value of AAI to 
identify those with asymptomatic PAD who are at risk for functional decline.   
More recently, low AAI was found to predict incident disability and gait speed decline in 
older adults living in the community [2].  In contrast to the previous study, the study population 
included individuals without clinically diagnosed PAD.  Cox proportional hazards models were 
used to test the associations of four categories of AAI with self-reported incident disability.  
Additionally, marginal models were used to analyze the associations of AAI categories with gait 
speed decline over six years.  The results suggested an inverse, dose-response relationship 
between AAI and risk of incident disability.  Participants with an AAI less than 0.9 declined on 
average 0.12 m/s over 6-year follow-up, an amount considered a clinically meaningful decline in 
physical function [6].  
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While these findings suggest local influences of PAD on mobility, it is unclear whether 
systemic vascular disease may influence physical function in older age.  In a recent study of this 
relationship, ultrasound imaging was used to measure carotid intima-media (IMT) thickness, a 
surrogate marker of subclinical atherosclerosis [7].  The authors identified an inverse association 
of IMT with walking speed in older adults without self-reported PAD.  This relationship was 
partially attenuated by adjustment for cognitive performance, in line with hypothesized 
mediation by cognitive function.  However, these results may be confounded by subclinical or 
undiagnosed PAD.  To clarify the potential local and systemic influences of vascular disease on 
mobility, we evaluated the associations of both AAI and PWV with gait speed decline over eight 
years in Health ABC. 
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3.0  METHODS 
3.1 POPULATION 
From 1997 to 1998 the Health ABC Study enrolled 3,075 Medicare-eligible nondisabled men 
and women aged 70-79 from Pittsburgh, Pa. and Memphis, Tenn., USA.  The population was 
52% women and 58% white with a mean age of 73.6 years.  Participants were recruited from a 
random sample of Medicare-eligible adults provided by the Health Care Financing 
Administration and other household members aged 70-79 were also eligible for recruitment.  
Exclusion criteria were difficulty walking without an assistive device, walking one quarter of a 
mile or climbing 10 steps without resting.    Both Institutional Review Boards of the University 
of Pittsburgh, Pa., as well as University of Tennessee at Memphis approved the study and 
written, informed consent was obtained from each volunteer.  Of the 3,075 participants enrolled 
in Health ABC, 2,103 had PWV, AAI and gait speed data at baseline.  Of these participants, we 
excluded those with either self-reported lower extremity revascularization or angioplasty (n = 
37), leaving 2,066 participants for analysis (mean age ± SD 73.6 ± 2.8 years, 48.1% men, 37.8% 
black).   
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3.2 ANKLE-ARM INDEX 
All Health ABC participants were eligible for ankle-arm index measurement except those with 
rashes, open wounds, bilateral amputations, or those unable to lie at 45 degrees or less.  
According to previously reported standard protocol [8], certified technicians measured pressures 
in the left or right arm and both ankles.  Participants were asked to lie recumbent or 
semirecumbent for at least 5 minutes before measuring blood pressure.  Standard blood pressure 
cuffs were applied to the right arm and each ankle (posterior tibial artery).  If blood pressures 
could not be obtained in the right arm, then the left arm was used (50 cases).  After palpation of 
the arteries, ultrasound gel was applied and an 8-MHz pencil Doppler probe (Parks Medical 
Electronics, Inc) was used with a standard manometer to measure systolic blood pressures.  The 
systolic blood pressure of the ankle was divided by the systolic blood pressure of the arm to 
create the ankle-arm index.  Measures were performed twice and the results were averaged.  The 
lower average value between the two legs was used to define the ankle-arm index. 
3.3 PULSE WAVE VELOCITY 
Aortic PWV was measured noninvasively via simultaneous Doppler-recorded carotid and 
femoral pulse waveforms (model 810A, 9.0- to 10-MHz probes, Parks Medical Electronics, Inc).  
A minimum of ten beats were recorded for each simultaneous recording site.  Three separate runs 
were recorded for each participant, and all usable runs were averaged to calculate the final PWV 
measure.  The distance between the carotid and femoral recording sites was measured above the 
surface of the body with a tape measure.  The time delay between the feet of the pressure waves 
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at each site was divided by the associated distance to calculate PWV in cm/s.  Replicate 
measures of PWV in 14 subjects revealed intraclass correlations of 0.88 between sonographers 
and 0.84 between readers [9]. 
3.4 GAIT SPEED 
Usual speed is a reliable, valid measure of physical function that predicts incident disability in 
older adults [4].  In Health ABC gait speed was assessed over a 20-meter straight course at 
baseline and annual (except for Year 7) follow-up over seven years.  Participants were instructed 
to walk at their usual pace from the starting point to the end of the course.  Timing began at the 
first footfall over the starting line and ended with the first footfall over the finishing line. 
3.5 RANDOM COEFFICIENT ANALYSIS 
Random coefficient analysis, a type of linear mixed model, provides the advantage of correcting 
for the correlation of observations within a subject over time.  The models account for 
heterogeneity between subjects by allowing the regression coefficients to vary randomly between 
subjects.  The responses for each subject are assumed to be independent observations conditional 
on the random effects.  Also, the random coefficients are assumed to have a multivariate normal 
distribution and the residuals a normal distribution [10]. 
This approach corrects for correlation within the data by dividing the total variance in the 
outcome variable into several components: variance explained by predictors, variance explained 
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by the random intercept and slope(s), and remaining variance.  Ignoring the correlation within 
data would lead to overestimated standard errors for within-subject factors, and underestimated 
standard errors for between-subject effects [11]. 
In the simplest form of the model, only the intercept is random: 
Yit = Β0i + Β1t + εit 
where Yit is the observation for subject i at time t, Β0i is the random intercept, Β1t is the 
coefficient for time, and εit  is the error for subject i at time t.  
The model may additionally allow the relationship of the outcome with time, or the slope 
with time, to vary randomly between subjects: 
Yit = Β0i + Β1it + εit 
where Yit is the observation for subject i at time t, Β0i is the random intercept, Β1t is the random 
coefficient for time, and εit  is the error for subject i at time t.  
Random coefficient models often consider a coefficient relating a predictor and an 
outcome as fixed, or constant between subjects.  In general, a factor is designated as fixed if it is 
one of a specific set of treatments or levels of interest.  If the levels of a factor are considered to 
be random sample from a larger population, the factor may be considered random [12].  The 
coefficients for both types of factors may be interpreted as population-averaged or subject-
specific; in reality, each coefficient combines both types of effects.  However, coefficients 
estimated by random coefficient analysis are often considered conditional, or within-subject 
effects.  This approach is often preferred over marginal, or population-averaged methods when 
inference is subject-specific, or when there is significant variation in the responses that cannot be 
explained by the covariates [11]. 
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     Finally, random coefficient models provide several advantages in longitudinal data 
analysis.  In addition to flexibly correcting for correlation within data, the models accommodate 
unequal spacing between time points.  The method also utilizes all available data throughout the 
study period, rather than excluding individuals with missing data as in the Analysis of Variance 
(ANOVA) method.  Finally, missing data in random coefficients models allowed to be missing at 
random (MAR), where the probability that an observation is missing is unrelated to the value of 
each covariate after controlling for another covariate.  This condition is less restrictive than the 
requirement of missing completely at random (MCAR), where the probability of missingness is 
assumed to be independent of unobserved or observed data [11].  
3.6 COVARIATES 
In addition to demographic variables (age, race, sex, and clinic site), we considered as potential 
confounders variables that were associated with both subclinical vascular disease and gait speed 
in the literature but did not lie on the expected causal pathway. These included smoking status, 
body-mass index, physical activity, prevalent coronary heart disease (CHD), diabetes, and 
hypertension.  We evaluated differences in these variables across quartiles of PWV, AAI and gait 
speed in the Health ABC cohort (Tables 1-3) using Chi-squared tests for categorical variables 
and analysis of variance for continuous variables.  Variables that were associated with either 
PWV or AAI and with gait speed at a significance level of 0.15 were selected as covariates in the 
adjusted models.  These included all variables except smoking status and CHD, which were not 
associated with gait speed.  Additionally, because peripheral arterial disease and PWV are 
important predictors of cerebrovascular disease [13] [9], we considered as potential mediators 
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prevalent cerebrovascular disease and performance on the Digit Symbol Substitution Test 
(DSST), a test of attention and psychomotor speed. 
Presence of comorbid conditions was determined from participant reports from the 
baseline visit.  BMI was calculated as measured weight in kilograms divided by measured height 
in meters squared.  Physical activity was assessed by questionnaire and used to calculated the 
kilocalories expended walking for exercise in the previous week.  Participants with at least 1,000 
kcal walking for exercise were defined as active.  Finally, the DSST is a paper-and-pencil task 
which requires participants are asked to copy as many symbols corresponding to numbers as 
possible in 90 s.  This test predicts morbidity and mortality in older adults [14] [15] and may be a 
marker of cerebral small vessel disease [15].  In these analyses, DSST performance is evaluated 
as a potential mediator of the relationships between PWV, AAI, and gait speed over time. 
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4.0  ANALYSIS 
We evaluated the relationships of baseline pulse wave velocity and ankle arm index with 20 
meter gait speed over time in 2, 066 Health ABC participants.  Gait speed was additionally 
measured at annual follow-up (except Year 7) through Year 8, for a total of seven measurements. 
All analyses were performed using STATA (College Station, TX). 
Plots of baseline gait speed by the subclinical vascular disease measures indicated that 
gait speed (m/s) decreased linearly with increasing PWV (cm/s) (Fig 1).  By contrast, we 
identified an inverted U-shaped relationship between AAI category and baseline gait speed.  The 
>1.3 – 1.4 AAI category had the fastest gait speed (mean (SD) 1.45 (0.22) m/s), while the lowest 
AAI (>0.7) and noncompressible categories had the slowest (mean (SD) 1.23 (0.22) m/s and 
mean (SD) 1.24 (0.22) m/s respectively).  To account for this nonlinear relationship, analyses of 
AAI in the whole sample categorized AAI in 0.1 increments and including noncompressible 
arteries.  Random coefficient models of AAI categories used the >1.3 – 1.4 category as the 
reference because participants in this category had the highest performance at baseline.   
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Figure 1. Mean gait speed (m/s) by PWV quintile and AAI category at baseline. 
 
For additional analyses of AAI as a continuous variable, we excluded participants with 
AAI > 1.4 (n = 26) or noncompressible arteries (n = 40), to preserve the linear relationship 
between AAI and gait speed in the remaining sample (AAI < 1.4, n = 2000) (Fig 1).  For these 
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analyses, we standardized AAI to allow comparison of the strengths of the relationships of AAI 
and PWV with gait speed.    
To evaluate the relationships between PWV and AAI with gait speed decline, we 
calculated the least squares means of gait speed at each year according to quartiles of baseline 
PWV and AAI, adjusted for age, race, sex, and site (Fig 2).  We then used random coefficient 
models to evaluate the relationships of PWV (SD) and AAI with gait speed over time.  
Continuous covariates were centered to simplify interpretation of model coefficients and to 
reduce multicollinearity.     
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Figure 2. Gait speed (m/s) decline over 8 years, by quartiles of PWV and AAI. The figure gives least squares 
means for gait speed adjusted for age, race, sex, and site.  AAI quartiles were calculated after excluding those 
with either AAI > 1.40 (n=26) or noncompressible arteries (n=40). 
  20
 4.1 RANDOM COEFFICIENT MODEL 
We evaluated the associations of PWV (continuous) and AAI (both continuous and categorical) 
with gait speed over time using separate random coefficient models for each measure.  Reduced 
models included a random intercept for subject, a random slope with time, clinic site and PWV 
or AAI as fixed effects, and an interaction term for PWV or AAI with time.  In a second model, 
we additionally adjusted for demographics (age, sex, and race) and the interaction of each 
covariate with time.  To build a full model, we additionally adjusted for confounders that were 
each significantly associated (p<0.05) with gait speed in an unadjusted random intercept model.  
Covariates that remained significant in a model adjusted for all others were retained in the 
model.  Controlling for these covariates, we then tested the significance of interactions of each 
covariate with time by fitting separate models for each interaction.  All significant interaction 
terms were included in a full model.  Interaction terms that remained significant in the full model 
were retained in a final parsimonious model.  Finally, to evaluate cognitive function as a possible 
mediator, we additionally adjusted each final model for prevalent cerebrovascular disease and 
Digit Symbol score.   
       Using this stepwise selection procedure we obtained identical final models for both PWV 
(SD) and AAI (0.1 categories) as predictors of gait speed over time.  These models are provided 
for PWV below.    
Model 1: Gait speedit = Β0i + Β1it + Β2PWV + Β3site + Β4PWV*time + εit 
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Model 2: Gait speedit = Β0i + Β1it + Β2PWV + Β3site + Β4PWV*time + Β5age  + Β6sex  + 
Β7race + Β8age*time  + Β9sex*time + Β10race*time + εit 
Model 3: Gait speedit = Β0i + Β1it + Β2PWV + Β3site + Β4PWV*time + Β5age  + Β6sex  + 
Β7race + Β8age*time + Β9sex*time + Β10race*time + Β11ΒΜΙ + Β12physical activity + 
Β13diabetes + Β14hypertension + Β15hypertension*time + εit 
where Yit is the observation for subject i at time t, Β0i is the random intercept, Β1t is the random 
coefficient for time, and εit  is the error for subject i at time t.  
No correlation structure was specified for the random coefficient models.  Because the 
correlations between repeated responses are of similar magnitude (Figure 2), the exchangeable 
structure is appropriate.  However, because specifying a random slope is equivalent to 
designating an exchangeable correlation structure, the unstructured option was selected to avoid 
‘over-correction.’ [8] 
4.2 RESULTS 
Tables 1-4 give the baseline characteristics of the cohort by quartiles of PWV, AAI, and gait 
speed.  Participants in higher quartiles of PWV were older, more likely to be male, black, 
exercise less, and have higher BMI, a history of smoking and comorbidities.  Those with low 
AAI or noncompressible arteries were older, more likely to be black and to have comorbidities.  
Those in lower quartiles of gait speed were older, more likely to be female, black, have higher 
BMI, exercise less, and have comorbidities. 
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Figure 1 gives the least squares means for gait speed at each year according to baseline 
quartiles of PWV and AAI, adjusted for age, race, sex and site.  For these analyses, participants 
with high AAI (>1.4) and noncompressible arteries were excluded.  Participants with PWV 
below the median and those with AAI in the lowest quartile performed consistently worse 
throughout the study period. 
In the random coefficient model adjusted for site, gait speed declined on average 0.041 
m/s per year (p<0.001) and each SD higher PWV was associated with a 0.019 m/s slower gait 
speed throughout the study period (p<0.001).  The relationship of PWV with gait speed over 
time was modestly attenuated after additional adjustment for age, sex, race, and the interaction of 
each covariate with time (Beta (SE) = -0.014 (0.004), p<0.001).  The associations of PWV with 
gait speed were further attenuated, but remained significant, after additional adjustment for BMI, 
physical activity, diabetes, hypertension, and the interactions of each covariate with time (Beta 
(SE) = -0.008 (0.004), p=0.03).  Finally, the interaction of PWV and time was nonsignificant in 
all models, indicating that the rate of gait speed decline did not differ by baseline PWV. 
To evaluate whether cerebrovascular disease may mediate the relationship between PWV 
and gait speed over time, we additionally adjusted the final model for Digit Symbol Substitution 
(DSS) score and prevalent cerebrovascular disease.  Adjustment for DSS attenuated the 
association of PWV with gait speed (Beta (SE) = -0.007 (0.004), p=0.08).  However, the 
relationship remained unchanged after adjustment for prevalent cerebrovascular disease. 
Random coefficients models of AAI (SD) indicated a stronger relationship of AAI with 
gait speed over time, compared to PWV.  In participants with AAI < 1.4, each SD lower AAI 
was associated with a 0.046 m/s slower gait speed throughout the study period (p<0.001).  The 
relationship was substantially attenuated after adjustment for demographic variables and their 
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interactions with time (Beta (SE) = 0.022 (0.004), p<0.001).  The coefficient for AAI was 
unchanged after further adjustment for risk factors and comorbidities and the interactions of 
covariates with time. 
Similar to results at baseline (Fig 1), analyses of AAI categories in the whole sample 
indicated an inverse U-shaped relationship of AAI with gait speed over time.  Participants with 
lowest AAI (≤ 0.7) and those with noncompressible arteries had the slowest gait speed over time: 
Beta (SE) = -0.21 (0.04), and Beta (SE) = -0.20 (0.04) respectively, compared to the reference 
category AAI >1.3 – 1.4 (p<0.001 for both).  These relationships were attenuated after 
adjustment for demographics and the interaction of each covariate with time: Beta (SE) =  -0.12 
(0.04), Beta (SE) = -0.13 (0.04) respectively (p<0.001 for both).  Further adjustment for BMI, 
physical activity, diabetes, and hypertension, and the interaction of covariates with time did not 
substantially change the coefficients for AAI. 
As in the PWV analyses, the interaction of AAI (continuous and categorical) and time 
was nonsignificant in adjusted models, indicating that baseline AAI was not associated with the 
rate of gait speed decline.  Further adjustment for DSS score and prevalent CBVD each modestly 
attenuated the coefficients for AAI. 
Residual plots were used to verify the assumptions of the random coefficients models.  
For the final models of PWV and AAI, plots of residuals vs. time did not suggest that the 
residual variance varies over time.  Normal probability plots of residuals did not reveal 
substantial departures from normality. 
Finally, missing observations were common throughout the study period (Table 8).  To 
evaluate the sensitivity of our models to missing data, we repeated the analyses in the subgroup 
of participants who had gait speed data at Year 8 (n = 1200).  In this subgroup, the coefficient for 
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PWV in the final model was substantially reduced and no longer significant (Beta (SE) = -0.003 
(0.005), p = 0.48).  However, the coefficient for AAI (SD) did not change substantially and 
remained significant (Beta (SE) = -0.020 (0.005), p = 0.000).  In the final model of AAI 
categories, the coefficients for AAI were slightly reduced compared to results in the whole 
sample.  The categories AAI ≤ 0.7, AAI 0.7-0.8 and noncompressible arteries remained 
significantly worse compared to the 1.3-1.4 category: Beta (SE) = -0.09 (0.04), p = 0.03 for AAI 
≤ 0.7; Beta (SE) = -0.09 (0.04), p = 0.04 for AAI 0.7-0.8; Beta (SE) = -0.13 (0.04), p = 0.05 for 
noncompressible arteries.  As in the analyses of the whole sample, none of the interactions of 
either subclinical measure with time were significant in the sensitivity analyses. 
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5.0  DISCUSSION 
In this well-functioning cohort of community-dwelling older adults, higher PWV and lower AAI 
were each associated with slower gait speed over time.  However, we identified no relationship 
of either subclinical measure with gait speed decline over eight years.  
This study builds on growing evidence of a vascular pathology underlying age-related 
mobility decline in older adults.  Recent research has identified an association of low AAI, a 
marker of peripheral arterial disease, with gait speed decline and incident functional limitation 
[2].  PAD may directly contribute to physical impairment via claudicating leg pain, muscle 
weakness, and reduced nerve function [2].   At the same time, new evidence suggests a potential 
systemic influence of subclinical atherosclerosis on physical function in nondisabled older adults 
[7].  This relationship may be mediated by cerebral small-vessel disease, which preferentially 
disrupts frontal-subcortical tracts involved in the execution of complex tasks such as walking [3]. 
The current study supports associations of both higher PWV and lower AAI with slower 
gait speed over time.  However, the estimated effect of elevated PWV was largely explained by 
underlying cardiovascular risk factors.  A small independent association of PWV with gait speed 
was modestly attenuated by adjustment for performance on a test of psychomotor speed.  These 
findings support our hypothesis that elevated arterial stiffness may influence physical function 
via reduced cognitive function; however, the potential role of arterial stiffness was modest in 
relation to AAI. 
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Our results underscore the local influences of subclinical PAD on mobility in advancing 
age.  Independent of risk factors and comorbidities, each SD lower AAI was associated with a 
0.022 m/s slower gait speed.  More strikingly, participants with AAI <0.7 and noncompressible 
arteries had 0.10 and 0.16 slower gait speeds over time, compared to those with AAI <1.3-1.4.  
An annual decline within this range is considered a disabling change in function [6].  These 
findings call attention to meaningfully reduced function in those with low AAI or 
noncompressible arteries.  
 While both PWV and AAI were associated with gait speed over eight years, we did not 
identify an association of either measure with the rate of decline. However, our analyses of AAI 
categories are limited by small sample sizes at the high and low ends of the AAI distribution and 
in the noncompressible category.  It is also possible that PWV and AAI influenced the rate of 
decline prior to our observation.  Our results may then reflect a “horse-racing effect” [16], where 
fast decliners perform worse at the time of observation.  Similarly, we observed consistently 
slower gait speeds in individuals with higher PWV and lower AAI.  
Although AAI and PWV were not associated with the rate of gait speed decline in our 
study, several covariates predicted accelerated decline over eight years.  In separate multivariate 
models of PWV and AAI as continuous variables, older age, male sex, white race, and 
hypertension were each associated with a faster rate of gait speed decline.  In models of AAI 
(SD), prevalent diabetes was also associated with faster decline.  The finding that men and 
whites declined faster was unexpected, given the faster baseline gait speed of these participants.  
These accelerated declines may reflect a floor effect in participants with poorer baseline 
performance. 
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Our finding that the high normal AAI category (>1.3-14) had the fastest gait speed was 
also unexpected.  In Health ABC, this category was associated with a higher risk of mortality 
compared to the >1.2-1.3 category, which carried the lowest risk [13].  This result may reflect 
arterial stiffness in those with high ankle pressures in the >1.3-1.4 range [13].  In the current 
study, the high performance observed in the >1.3-1.4 category may be explained by the large 
proportion of men (80%) in this category, since men were faster than women throughout the 
study period. 
Strengths of our study include a large, community-based population, availability of  
important covariates, and use of a reliable, valid measure of physical function that predicts 
mobility limitation [4].  An additional advantage is the analysis of noncompressible arteries, 
which reflect vascular stiffness due to calcification of the leg arteries.  Our study is limited by 
high proportion of missing observations throughout the study period.  Sensitivity analyses which 
excluded participants with a missing final observation suggest that our analyses of PWV, but not 
AAI, are sensitive to missing data.  Because participants with high PWV were more likely to 
withdraw from the study, our results may underestimate the associations of PWV with gait speed 
in the population. 
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6.0  CONCLUSIONS 
Our results underscore the relationship of subclinical vascular disease, particularly low AAI and 
noncompressible arteries, with poor mobility in older adults.  The association of PWV with gait 
speed was modest in relation to AAI, emphasizing the potential role of subclinical or 
undiagnosed PAD in functional decline.  Strategies to prevent disability in aging should address 
the control of subclinical vascular disease, particularly PAD. 
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Mean ± SD or % 
Table 1. Baseline characteristics of the cohort by quartiles (range in parentheses) of PWV (cm/s). 
 
 Total  
(312-2998) 
 
n=2066 
Q1 
(312-636) 
 
n=517
Q2 
(637-799) 
 
n=516
Q3 
(799-1045) 
 
n=517
Q4 
(1046-2998) 
 
n=516 
 
p-value 
Age, years 
 
73.6 ± 2.8 73.3 ± 2.8 73.4 ± 2.8 73.9 ± 2.9 73.9 ± 2.8 0.000 
Men  
 
48.1 44.3 44.4 50.1 53.7 0.004 
Black  
 
37.8 32.3 36.8 39.3 42.8 0.005 
BMI, kg/m2 
 
27.3 ± 4.7 26.1 ± 4.4 27.4 ± 4.5 28.1 ± 4.8 27.4 ± 4.8 0.000 
Curr
form
 57.0 0.002 ent or 
er smoker 
54.7 48.0 54.3 59.4
Phys
> 1
 30.2 0.035 ical activity 
000 kcal/wk 
33.3 38.3 33.0 31.7
Cor
diseas
 18.1 0.097 onary heart 
e  
17.4 15.0 16.1 20.6
Diab  19.3 0.000 etes 14.0 8.0 12.1 16.7
Hype
 
 59.4 0.000 rtension 48.2 35.8 45.9 51.7
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Table 2. Baseline characteristics of the cohort by AAI category. 
Median (IQR) or % 
 Total 
sample 
  
(n=2066) 
 
? 0.70 
 
 
(n=86) 
>0.70 -
?0.80 
 
(n=52) 
 
>0.80 - 
?0.90 
 
(n=106) 
 
>0.90 - 
?1.00 
 
(n =242 ) 
 
>1.00 - 
?1.10 
 
(n=588) 
 
>1.10 - 
?1.20 
 
(n=586) 
 
>1.20 - 
?1.30 
 
(n=270) 
 
>1.30 - 
?1.40 
 
(n=70) 
 
>1.40 
 
 
(n=26) 
NC 
 
 
(n=40) 
 
p 
value 
Age, years* 
 
73 (5) 74 (5) 74 (4) 74 (5) 74 (5) 73 (5) 73 (4) 73 (4) 74 (4) 72 (3) 75 (4) 0.006 
Men 
 
48.1 43.0 46.2 48.1 38.0 39.5 50.2 61.5 80.0 57.7 67.5 0.000 
Black  
 
37.8 61.6 53.9 53.8 48.8 41.5 30.7 20.4 24.3 19.2 60.0 0.000 
BMI, kg/m2*  
 
26.7 
(5.8) 
28.0 
(5.6) 
26.8 
(6.7) 
26.5 
(5.7) 
27.0 
(7.1) 
26.4  
(5.7) 
26.6 
(5.6) 
26.9 
(5.4) 
28.2 
(6.0) 
29.2 
(5.9) 
25.1 
(6.0) 
0.007 
Current or former 
smoker  
54.6 69.8 69.2 65.1 57.4 55.8 51.7 47.4 47.1 46.2 50.0 0.001 
Physical activity < 
1000 kcal/wk  
33.3 24.4 32.7 19.8 29.8 32.5 35.8 37.8 47.1 34.6 30.0 0.005 
Coronary heart 
disease  
17.4 24.4 38.0 26.7 18.0 17.1 13.5 16.7 14.5 7.7 28.2 0.000 
Diabetes  
 
14.0 26.7 26.9 23.6 16.6 10.2 11.5 12.3 15.7 11.5 30.8 0.000 
Hypertension 48.2 64.7 67.3 52.4 54.4 49.5 43.7 38.5 42.9 50.0 57.5 0.000 
  
NC = Noncompressible arteries 
*Kruskal-Wallis rank test of equal medians
Table 3. Baseline characteristics of the cohort by quartiles (range in parentheses) of gait speed (m/s). 
Mean ± SD or %
 Total   
(0.38-2.47) 
 
n=2066 
Q1 
(0.38-1.18) 
 
n=542 
Q2 
(1.19-1.33) 
 
n=515 
Q3 
(1.34-1.50) 
 
n=509 
Q4 
(1.51-2.47) 
 
n=500 
 
p-value 
Age, years 
 
73.6 ± 2.8 74.1 ± 3.0 73.8 ± 2.8 73.5 ± 2.8 73.0 ± 2.6 0.000 
Men  
 
48.1 33.8 41.0 54.4 64.6 0.000 
Black  
 
37.8 61.6 39.6 28.9 19.2 0.000 
BMI, kg/m2 
 
27.3 ± 4.7 28.6 ± 5.7 27.4 ± 4.5 26.8 ± 4.0 26.0 ± 3.6 0.000 
Current or 
former smoker  
54.7 54.1 54.8 56.4 53.4 0.799 
Physical activity 
> 1000 kcal/wk  
33.3 19.0 25.6 38.7 51.2 0.000 
Coronary heart 
disease  
17.4 18.6 15.8 19.0 16.2 0.422 
Diabetes  
 
14.0 19.3 15.0 13.0 8.2 0.000 
Hypertension  
 
48.2 57.2 50.0 44.5 40.3 0.000 
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Table 4. Baseline characteristics of the cohort by quartiles (range in parentheses) of gait speed (m/s). 
Mean ± SD, Median (IQR) or %
 Total   
(0.38-2.47) 
 
n=2066 
Q1 
(0.38-1.18) 
 
n=542 
Q2 
(1.19-1.33) 
 
n=515 
Q3 
(1.34-1.50) 
 
n=509 
Q4 
(1.51-2.47) 
 
n=500 
 
p-value 
PWV (cm/s)* 
 
799 (409) 831 (411) 827 (413) 799 (422) 756 (378) 0.0009 
AAI % <0.9 
 
11.8 17.9 13.8 8.6 6.4 0.0000 
Cerebrovascular 
disease 
7.1 9.6 7.8 6.3 4.6 0.015 
DSS score 
 
36.8 ± 14.3 30.6 ± 14.4 36.4 ± 13.8 38.9 ± 13.2 41.8 ± 13.5 0.0000 
*Kruskal-Wallis rank test of equal medians  
 
 
Table 5. Regression coefficients and standard errors (values in parentheses) estimated by random coefficient 
analysis of PWV as a predictor of gait speed (m/s) over eight years. 
(SD) Model 1 Model 2 Model 3 
PWV -0.019 (0.005)+ -0.014 (0.004)+ -0.008 (0.004)* 
Time  -0.041 (0.001)+ -0.040 (0.001)+ -0.038 (0.001)+ 
PWV *Time -0.001 (0.001) -0.001 (0.001) -0.001 (0.001) 
 
* p<0.05 
+ p<0.01 
 
Model 1 adjusted for site  
Model 2 additionally adjusted for age, gender, race, and interaction of each covariate with time 
Model 3 additionally adjusted for BMI, physical activity, diabetes, hypertension, and interaction of 
each covariate with time   
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Table 6. Regression coefficients and standard errors (values in parentheses) estimated by random coefficient 
analysis of AAI as a predictors of gait speed (m/s) over eight years, after exclusion of those with AAI > 1.4 or 
noncompressible arteries.  
(SD) Model 1 Model 2 Model 3 
AAI 0.046 (0.005)+ 0.022 (0.004)+ 0.022 (0.004) + 
Time -0.040 (0.001)+ -0.039 (0.001)+ -0.037 (0.001) + 
AAI*Time 0.000 (0.001) 0.001 (0.001) 0.000 (0.001) 
 
* p<0.05 
+ p<0.01 
Model 1 adjusted for site  
Model 2 additionally adjusted for age, gender, race, and interaction of each covariate with time 
Model 3 additionally adjusted for BMI, physical activity, diabetes, hypertension, and interaction of 
each covariate with time   
      
 
   
 
Table 7. Regression coefficients and standard errors (values in parentheses) estimated by random coefficient 
analysis of AAI as a predictor of gait speed (m/s) over eight years. 
AAI Category Model 1 Model 2 Model 3 
<  -0.19 (0.03)+ -0.10 (0.03)+ -0.10 (0.03)+  0.7
> 0.7 – 0.8 -0.18 (0.04)+ -0.10 (0.03)+ -0.11 (0.03)+ 
> 0.8 – 0.9 -0.14 (0.03)+ -0.06 (0.03)* -0.08 (0.03)+ 
> 0.9 – 1.0 -0.14 (0.03)+ -0.06 (0.03)* -0.07 (0.02)+ 
> 1.0 – 1.1 -0.10 (0.03)+ -0.04 (0.02) -0.05 (0.02)* 
> 1.1 – 1.2 -0.07 (0.03)+ -0.03 (0.02) -0.05 (0.02)* 
> 1.2 – 1.3 -0.02 (0.03) -0.02 (0.02) -0.02 (0.02) 
> 1.4 -0.04 (0.05) -0.04 (0.04) -0.04 (0.04) 
Noncompressible -0.20 (0.04)+ -0.13 (0.04)+ -0.16 (0.04)+ 
Time -0.046 (0.004)+ -0.042 (0.004)+ -0.041 (0.004)+ 
Reference: >1.3 – 1.4 
 
* p<0.05 
+ p<0.01  
Model 1 adjusted for site  
Model 2 additionally adjusted for age, gender, race, and interaction of each covariate with time 
Model 3 additionally adjusted for BMI, physical activity, diabetes, hypertension, and interaction of 
each covariate with time   
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Table 8.  Distribution of missing gait speed observations throughout the study period.   
Number of Missing 
Observations 
Participants (N) % 
0 1,012 48.98 
1 412 19.94 
2 173 8.37 
3 129 6.24 
4 108 5.23 
5 123 5.95 
6 109 5.28 
Total 2,066 100.00 
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APPENDIX 
STATA CODE 
STATA (Version 10) code used for the final random coefficient models is as follows: 
 
I. PWV (SD) as a predictor of gait speed (m/s) over eight years 
Model 1 
xtmixed gait pwv_stan memphis visit pwv_vis || habcid: visit, cov(unstr) mle 
Model 2 
xtmixed gait pwv_stan memphis visit pwv_vis age1_cent male black age_visit male_visit 
black_visit || habcid: visit, cov(unstr) mle 
Model 3 
xtmixed gait pwv_stan memphis visit pwv_vis age1_cent male black age_visit male_visit 
black_visit bmi_cent physrec pdiab phbp1yn phbp1yn_visit || habcid: visit, cov(unstr) mle 
 
II. AAI (SD) as a predictor of gait speed (m/s) over eight years 
Model 1 
xtmixed gait minaai_stan visit memphis minaai_vis || habcid: visit, cov(unstr) mle, if aaicat < 10  
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Model 2 
xtmixed gait minaai_stan visit memphis minaai_vis age_cent male black age_visit male_visit 
black_visit || habcid: visit, cov(unstr) mle, if aaicat < 10  
Model 3 
xtmixed gait minaai_stan visit memphis minaai_vis age_cent male black age_visit male_visit 
black_visit bmi_cent phbp1yn physrec pdiab pdiab_visit phbp1yn_visit || habcid: visit, 
cov(unstr) mle, if aaicat < 10  
 
III. AAI (0.1 categories) as a predictor of gait speed (m/s) over eight years 
Model 1 
xi: xtmixed gait i.aaicat*visit memphis || habcid: visit, cov(unstr) mle 
Model 2 
xi: xtmixed gait i.aaicat*visit memphis age_cent male black age_visit male_visit black_visit || 
habcid: visit, cov(unstr) mle 
Model 3 
xi: xtmixed gait i.aaicat*visit memphis age_cent male black age_visit male_visit black_visit 
bmi1_cent phbp1yn physrec pdiab phbp1yn_visit || habcid: visit, cov(unstr) mle 
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